KLOW 80mg

KLOW 80mg – Advanced Multi-Peptide Research Blend
KLOW is a high-purity lyophilised research compound formulated as a multi-peptide blend, supplied in a sterile sealed vial containing a total of 80mg.
This formulation combines multiple well-characterised peptides, manufactured under strict quality standards to ensure consistency, stability, and reliability for laboratory applications.
⚠️ Note: Must be reconstituted with bacteriostatic (BAC) water prior to use.
🔬 Composition
GHK-Cu – 50mg
BPC-157 – 10mg
TB-500 – 10mg
KPV – 10mg
🧪 Technical Specifications
Synonyms: Multi-peptide blend
Chemical Formula:
GHK-Cu: C₁₄H₂₄N₆O₄Cu
BPC-157: C₆₂H₉₈N₁₆O₂₂
TB-500: C₂₂₁H₃₅₀N₆₈O₆₅S
KPV: C₁₇H₂₉N₅O₆
CAS Numbers:
GHK-Cu: 89030-95-5
BPC-157: 137525-51-0
TB-500: 77591-33-4
KPV: 820964-72-5
Molecular Weight: Approx. 8,000+ g/mol (combined)
Purity: ≥99.0% per component (validated via COA)
Peptide Lengths:
GHK-Cu: 3 amino acids
BPC-157: 15 amino acids
TB-500: 43 amino acids
KPV: 3 amino acids
Solubility: Fully soluble in water (H₂O)
Quality Verification: Confirmed via RP-HPLC analysis
📦 Storage & Handling
Store dry at 2–8°C
Protect from light and heat
After reconstitution: refrigerate and use within 6 weeks
🛡️ Quality Assurance
Manufactured in a GMP-compliant ISO 9001:2008 facility, with each batch undergoing strict quality control and analytical verification.
≥99% purity guaranteed
Fully batch tested
LPS-free
⚠️ Product Disclaimer
This product is intended strictly for research purposes only and is limited to scientific research and educational use.
It is not intended for human consumption, medical, veterinary, or therapeutic use.
This compound is an investigational material and has not been approved by any regulatory authority for use outside of a controlled research environment.
By purchasing this product, you acknowledge and accept full responsibility for its proper handling, storage, and use in accordance with all applicable laws and regulations.
No claims are made regarding safety, efficacy, or intended use beyond laboratory research.